Search
Browse
Statistics
Feeds

New phenanthrenequinones from Cymbidium ensifolium roots and their anti-inflammatory activity on lipopolysaccharide-activated BV2 microglial cells

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
793kB
[thumbnail of Supporting Material]
Preview
PDF (Supporting Material) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
4MB

Item Type:Article
Title:New phenanthrenequinones from Cymbidium ensifolium roots and their anti-inflammatory activity on lipopolysaccharide-activated BV2 microglial cells
Creators: Thant, M.T., Hasriadi, H., Poldorn, P., Jungsuttiwong, S. ORCID logoORCID: https://orcid.org/0000-0001-5943-6878, Rojsitthisak, P. ORCID logoORCID: https://orcid.org/0000-0003-1391-6993, Böttcher, C. ORCID logoORCID: https://orcid.org/0000-0002-6226-586X, Towiwat, P. ORCID logoORCID: https://orcid.org/0000-0001-9394-4622 and Sritularak, B. ORCID logoORCID: https://orcid.org/0000-0001-8352-4122
Abstract:The roots of Cymbidium ensifolium yielded a total of 17 compounds, comprising two new compounds (1-2), one new natural product (3), and 14 known compounds (4-17). The structures of new compounds were determined through the analysis of their spectroscopic data, including NMR, MS, UV, FT-IR, optical rotation, and CD. The anti-inflammatory activity of the isolated pure compounds was assessed using lipopolysaccharide-activated BV2 microglial cells. Compounds 1, 3, 6, 12, 14, and 16 showed the ability to reduce LPS induced NO release in BV2 microglial cells, with IC(50) values of 9.95 ± 2.13, 8.77 ± 3.78, 2.39 ± 0.91, 6.69 ± 2.94, 2.96 ± 1.38, 8.42 ± 2.99 μM, respectively and reduced the secretion of proinflammatory mediators (TNF-α, IL-6, MCP-1) in a concentration-dependent manner. Furthermore, the mechanistic role of the compound 3 was determined, which demonstrated its ability to inhibit the nuclear factor-κB (NF-κB) pathway through decreasing phosphorylation of p65 subunits.
Source:RSC Advances
ISSN:2046-2069
Publisher:Royal Society of Chemistry
Volume:14
Number:39
Page Range:28390-28400
Date:5 September 2024
Official Publication:https://doi.org/10.1039/d4ra04761c
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library